The latest myeloma news
Patients with relapsed multiple myeloma treated with the immunotherapy teclistamab lived significantly longer and remained…
An artificial intelligence-based tool may help physicians determine which newly diagnosed multiple myeloma patients are…
A phase 2 trial, CAR-PRISM, suggests that early use of CAR T cell therapy may…
A new study maps the immune cell landscape of bone marrow in patients with multiple…
A new study helps explain why some people with multiple myeloma stay in remission for…
Scientists have identified a more accurate way of predicting which patients with multiple myeloma, a…
Researchers at Duke University, USA, have shown that blocking an enzyme involved in iron regulation…
Researchers from Mass General Brigham, the Broad Institute of MIT and Harvard, USA, have identified…
On July 2, 2025, the Food and Drug Administration granted accelerated approval to linvoseltamab-gcpt, a…
A new risk assessment score developed by researchers at Dana-Farber Cancer Institute and the Broad…